Target Price Range
Analyst price targets
Free account| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — |
Analyst estimates 2021–2023 Powerpack |
Low Price | ||
| — | — | — | — | — | — | — | — | — | — | High Price | |||
| — | — | — | — | — | — | — | 505 | 482 | 189 |
Employees
|
|||
| — | — | — | — | — | 0 | 0 | 3 | 4 | 6 |
Revenue/Emp
|
|||
| — | — | — | — | — | 483 | 622 | 1,368 | 1,897 | 1,164 |
Revenue
|
|||
| — | — | — | — | — | 0.83% | 1.13% | 0.88% | 0.76% | (0.13%) |
Gross Margin
|
|||
| — | — | — | — | — | (17) | (16) | (38) | (28) | (50) |
EBT
|
|||
| — | — | — | — | — | (3.52%) | (2.57%) | (2.78%) | (1.46%) | (4.29%) |
EBT Margin
|
|||
| — | — | — | — | — | (17) | 0 | 0 | (28) | (50) |
Net Income
|
|||
| — | — | — | — | — | 0 | 0 | 0 | 0 | 0 |
Depreciation
|
|||
| — | — | — | — | — | 69.00 | 88.86 | 195.43 | 274.69 | 150.40 |
Revenue/Sh
|
|||
| — | — | — | — | — | (0.06) | (0.05) | (0.12) | (4.03) | (6.30) |
Earnings/Sh
|
|||
| — | — | — | — | — | (3.22) | (3.86) | (2.91) | (1.99) | (4.63) |
Cash Flow/Sh
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | (0.04) | 0.33 |
Capex/Sh
|
|||
| — | — | — | — | — | (3.22) | (3.86) | (2.91) | (2.03) | (4.30) |
Free CF/Sh
|
|||
| — | — | — | — | — | 0.00 | 0.13 | (1.28) | (4.50) | (0.55) |
Book Value/Sh
|
|||
| — | — | — | — | — | 7 | 7 | 7 | 7 | 8 |
Shares
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PE Ratio
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.05 | 0.01 |
PS Ratio
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.05 | (0.01) |
EV/Sales
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/FCF
|
|||
| — | — | — | — | — | (23) | (27) | (20) | (14) | (36) |
Op' Cash Flow
|
|||
| — | — | — | — | — | 0 | 0 | 0 | 0 | 3 |
Capex
|
|||
| — | — | — | — | — | (23) | (27) | (20) | (14) | (33) |
FCF
|
|||
| — | — | — | — | — | — | 12 | 16 | (27) | (5) |
Working Cap'
|
|||
| — | — | — | — | — | — | 33 | 26 | 6 | 11 |
Total Debt
|
|||
| — | — | — | — | — | — | 17 | 25 | (2) | (43) |
Net Debt
|
|||
| — | — | — | — | — | — | 1 | (9) | (31) | (4) |
Sh' Equity
|
|||
| — | — | — | — | — | 0.00% | (28.41%) | 0.00% | (78.56%) | (57.21%) |
ROA
|
|||
| — | — | — | — | — | — | 0.00% | 0.00% | 0.00% | 0.00% |
ROIC
|
|||
| — | — | — | — | — | 0.00% | 396.55% | 941.81% | 138.75% | 284.23% |
ROE
|
|||
predictions in italic, sparklines do not include predictions
Fiscal years to Dec 2020 · latest quarter Jun 2021
MOLECULAR DATA peers in Chemicals
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| ACNT Ascent Industries Co. | $131.9M | 0.0× | Compare |
| BAK Braskem S.A. | $272.2M | 0.0× | Compare |
| ASIX AdvanSix | $425.3M | 0.0× | Compare |
| VHI Valhi, Inc. | $454.6M | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| ASPI ASP Isotopes Inc. | $466.1M | 0.0× | Compare |
| RYAM Rayonier Advanced Materials Inc. | $591.9M | 0.0× | Compare |
| TROX Tronox Holdings PLC | $643.6M | 0.0× | Compare |
| LXU Lsb Industries Inc. | $726.5M | 19.8× | Compare |
MOLECULAR DATA (MKD) Latest News
No news matches these filters.